Ivermectin as a possible treatment for COVID-19

Not Applicable

Completed

• Conditions: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

• Registration Number: CTRI/2020/08/027225
• Lead Sponsor: AIIMS Patna

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-10-31
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 115

Inclusion Criteria

Patients admitted with COVID-19 with mild to moderate severity

Exclusion Criteria

History of allergy to Ivermectin

Unwillingness to participate in the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
egative RT-PCRTimepoint: Day 6

Secondary Outcome Measures

Name	Time	Method
Discharge by day 10Timepoint: Day 10;ICU AdmissionTimepoint: NA;In-hospital mortalityTimepoint: NA;Mechanical VentilationTimepoint: NA